Daklinza (daclatasvir)
Share
Follow Us
How can I get assistance paying for Daklinza? Is Daklinza covered by insurance?
UPDATE: Bristol Myers Squibb discontinued Daklinza effective June 2019.
Bristol-Myers Squibb, the developer of Daklinza, offers support through the Patient Support Connect program. Along with care counselors you can contact them for more information regarding a co-pay program for eligible patience and to help with insurance. For more information please visit www.patientsupportconnect.com.
Contact your insurance company directly for information regarding coverage of Daklinza.
Last Updated: June 2019
FDA Approved Daklinza (Daclatasvir) for the Treatment of Patients with Chronic Hepatitis C Genotype 3. http://news.bms.com/press-release/fda-approves-daklinza-daclatasvir-treatment-patients-chronic-hepatitis-c-genotype-3, Bristol-Myers Squibb Company. Retrieved July 27, 2015.
Financial Help Info for Daklinza (daclatasvir) . http://www.daklinza.bmscustomerconnect.com/support, Bristol-Myers Squibb Company. Retrieved July 27, 2015.
Highlights of Prescribing Information - DAKLINZA. http://packageinserts.bms.com/pi/pi_daklinza.pdf, Bristol-Myers Squibb Company. Retrieved July 27, 2015.
Patient Support Connect. http://www.patientsupportconnect.bmscustomerconnect.com/, Bristol-Myers Squibb Company. Retrieved July 27, 2015.
